In a major leap forward for the precision fermentation industry, Paris-based biotech company Standing Ovation has raised €3.75 million in Series A+ funding. The funds will be used to fuel the growth of the company’s flagship product, Advanced Casein, a protein ingredient aimed at revolutionizing the dairy sector with animal-free, precision-fermented alternatives. This new capital, which will enable expansion in the USA by 2025, builds on an impressive financial foundation, bringing the total raised by the company to €23 million in just four years.
Expansion of Funding and Partnership
The recent €3.75 million funding is part of Standing Ovation's Series A+ round, which adds to the €12 million raised in the original Series A round in 2022. The company’s backers include some of the most prominent names in venture capital and the food technology industry, such as Astanor Ventures, Peakbridge, Seventure, Good Startup, Big Idea Ventures, and the industrial giant Bel Group. In addition, the French government and Bpifrance have contributed €3 million to accelerate the production of fermented caseins, signaling significant public and private support for this innovative company.
Standing Ovation’s precision-fermented casein offers the same nutritional and functional properties as traditional dairy-based casein, but without the environmental and ethical concerns of animal farming. This breakthrough ingredient has the potential to disrupt not only the dairy industry but the entire global agri-food market.
The Only Player Mastering Fermentative Casein Production
Standing Ovation has positioned itself as the leader in fermentative casein production, a fact highlighted by Laetitia de Panafieu, a representative from Astanor Ventures who sits on the company’s Supervisory Board. “We are proud to support Standing Ovation, the only player mastering fermentative casein production, which will soon produce on an industrial scale to meet the needs of the agri-food industry and consumers,” de Panafieu commented.
The potential for this innovation is immense. With the growing demand for sustainable, ethical, and environmentally friendly food alternatives, Standing Ovation is poised to address a significant market need. This latest investment signals confidence from industry leaders in the company's ability to mass-produce its animal-free casein and meet the burgeoning demand for alternative proteins.
It’s worth noting that Standing Ovation’s announcement comes at a time when Europe’s fermentation sector is experiencing record growth. In the first half of 2024 alone, the sector raised €164 million in funding, surpassing the total for all of 2023. This reflects the increasing interest and investment in fermentation as a pivotal technology for future food production, driven by consumer demand for healthier and more sustainable alternatives.
A New Leadership Vision: Yvan Chardonnens Appointed CEO
Alongside its funding announcement, Standing Ovation also introduced a significant leadership change: the appointment of Yvan Chardonnens as CEO. Chardonnens, who brings over 30 years of experience in the global B2B sector, is expected to lead the company into its next phase of growth. His previous roles at companies like Oterra, Firmenich, and International Flavors & Fragrances (IFF) have equipped him with the expertise to scale the company’s production and expand its market presence internationally.
Chardonnens praised the company’s achievements under its co-founder, Romain Chayot, stating: “Under Romain’s leadership, Standing Ovation has accomplished key technological, operational, and financial milestones in just four years to be ready for its next phase of industrial-scale growth.”
Chardonnens’ appointment signals Standing Ovation’s readiness to move from an innovation-driven startup to an industrial-scale producer capable of supplying the global food industry. His experience with plant-based ingredients at Roquette and his leadership at Barry Callebaut, a global leader in chocolate and cocoa, further indicate his ability to scale sustainable solutions for the food sector.
The Case for Animal-Free Casein
Standing Ovation’s core product, Advanced Casein, is the result of cutting-edge precision fermentation technology. Casein is a critical protein in dairy products, providing the texture and mouthfeel that consumers expect from cheese, milk, and other dairy-based foods. The company’s animal-free casein delivers the same functional and nutritional benefits but is produced through a fermentation process that eliminates the need for animal farming.
What sets this product apart is its environmental and health benefits. According to Standing Ovation, its fermented caseins produce ten times fewer carbon emissions and require significantly less water and land compared to traditional dairy farming. Additionally, the casein is free from antibiotics and GMOs, making it a cleaner and safer option for consumers.
The company's partnership with the Bel Group, a multinational cheese leader known for brands like The Laughing Cow, Babybel, and Boursin, underscores the potential for animal-free casein to transform the dairy industry. By collaborating with established players, Standing Ovation is well-positioned to integrate its fermented proteins into a variety of dairy alternatives.
Moving Towards Mass Production and Global Distribution
As Standing Ovation transitions to industrial-scale production, the company is focused on obtaining the necessary regulatory approvals and fine-tuning its go-to-market strategy. The goal is to mass-produce and distribute Advanced Casein globally, beginning with the USA in 2025.
Co-founder Romain Chayot, who has now taken on the role of managing director, expressed his optimism for the future: “After four years of research and innovation to develop our manufacturing and industrial production process, now is the time to accelerate to mass-produce and distribute Advanced Casein® in the global agri-food market.”
In just four years, Standing Ovation has established itself as a trailblazer in the precision fermentation space. By focusing on the production of animal-free casein, the company addresses both the sustainability challenges of the traditional dairy industry and the growing consumer demand for alternative proteins. The support from major investors, strategic partnerships with established food brands, and the appointment of a seasoned CEO indicate that Standing Ovation is well on its way to becoming a key player in the future of food.
With €23 million in funding and a clear path to mass production, Standing Ovation is set to play a pivotal role in reshaping the dairy landscape. As the company continues to innovate and expand, it is positioned to not only meet the needs of the agri-food industry but also contribute to a more sustainable and ethical global food system.
Standing Ovation’s successful funding round and its strategic leadership appointment mark a new chapter in the company's journey to revolutionize the dairy industry. With its unique animal-free casein product, the company is poised to become a key driver in the shift towards sustainable, ethical, and scalable food solutions. As global demand for alternative proteins grows, Standing Ovation is well-equipped to lead the charge in the fermentation-driven future of food.
Comments